Flash News: US stocks of weight-loss concept companies saw mixed performance, with Ventyx Biosciences falling by 37.78%, Viking Therapeutics down 6.57%, Bojian down 2%, and Shuodi Biosciences dropping by about 1.2%. “Affordable weight loss drug company” Hims fell by over 0.8%, Anjin dropped by over 0.5%, ETF HRTS fell by over 0.4%, Fortune Pharma, Lilly, and Novo Nordisk ADR rose by up to 0.99%, Abbott rose by over 1%, and Roche Holdings ADR rose by over 1.3%.
